The study focuses on first-trimester pregnancy termination. Medical abortion using Misoprostol alone or in combination with Methyl Ergometrine is commonly used to safely terminate early pregnancies and avoid surgical intervention.. Spontaneous abortion
Conditions
Interventions
Intervention 1: Intervention group: Participants in the intervention group receive a single dose of 800 µg Misoprostol vaginally combined with 0.2 mg Methyl Ergometrine intramuscularly immediately aft
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women aged 18 to 45 years Pregnancy = 12 weeks confirmed by ultrasound Eligible for medical abortion and willing to provide informed consent
Exclusion criteria
Exclusion criteria: Ectopic or molar pregnancy History of allergy to prostaglandins or ergot alkaloids Contraindications to misoprostol or methyl ergometrine (e.g., asthma, hypertension)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of complete abortion (no need for surgical intervention). Timepoint: 24 hours, 7 days, and 14 days after intervention. Method of measurement: Assessed by transvaginal ultrasound and clinical evaluation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to expulsion of pregnancy products. Timepoint: 24 hours, 7 days, and 14 days after intervention. Method of measurement: Recorded by clinical assessment and patient report.;Side effects including bleeding, nausea, vomiting, diarrhea, and abdominal pain. Timepoint: 24 hours, 7 days, and 14 days after intervention. Method of measurement: Assessed using standardized questionnaires and clinical evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mozhgan Mokhtari
Iran University of Medical Sciences
Outcome results
None listed